People with schizophrenia are at elevated risk of developing type 2 diabetes. Increased metabolic risk factors are associated with other physical disorders such as cardiovascular diseases and reduced life expectancy of up to 10 years in people with type 2 diabetes and up to 15-20 years due to schizophrenia. A decision model is constructed to estimate the cost-effectiveness of the group-based life style intervention, relative to that of usual care for people aged 40 and over with chronic schizophrenia (mean duration of 17 years) and type 2 diabetes (mean duration of 8 years). A group-based lifestyle intervention is a promising option for middle-aged adults with chronic schizophrenia and comorbid type 2 diabetes, considering BMI loss achieved and QALYs gained.
Science Journals may include various types of articles such as, letters, short communications, review articles, research articles, case reports, editorials, and other supplementary articles. Science Journals represent the collaborative efforts of many scientists and scholars from various disciplines.
Last date updated on November, 2020